Announcements Trials
Browse Landscape

Status

Unknown 32Completed 28Recruiting 16Not yet recruiting 5Withdrawn 2Terminated 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 44Observational 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 138Neoplasms 134Lung Neoplasms 68Prostatic Neoplasms 67Carcinoma, Non-Small-Cell Lung 58Colorectal Neoplasms 45Multiple Myeloma 37Pancreatic Neoplasms 34Melanoma 32Brain Neoplasms 31Head and Neck Neoplasms 30Neoplasm Metastasis 28Ovarian Neoplasms 27Liver Neoplasms 27Carcinoma, Hepatocellular 27Leukemia, Myeloid, Acute 25Colonic Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 20Leukemia, Lymphocytic, Chronic, B-Cell 20Esophageal Neoplasms 20Carcinoma, Renal Cell 20Lymphoma, Non-Hodgkin 19Urinary Bladder Neoplasms 18Stomach Neoplasms 18Glioblastoma 18Uterine Cervical Neoplasms 17Sarcoma 17Lymphoma, Follicular 17Lymphoma, Large B-Cell, Diffuse 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Observational × Adenocarcinoma of Lung × Clear all
NCT02121925 2017-09-05

ONC003

Myriad Genetic Laboratories, Inc.

Terminated
227 enrolled
Thoracic

Adenocarcinoma of Lung, Lung Neoplasms

NCT02715102 2017-08-21

Circulating Tumor DNA in Patients at High Risk for Lung Cancer

Pathway Genomics

Terminated
39 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡